Mideast Stocks - Factors to watch on December 1
Emirates NBD drags Dubai; Egypt snaps losing streak
Reuters News - 01 Dec 2019
Dallah Healthcare Company (4004.SE)
Also known as: DHC, Dallah Health
43.00 SAR -0.10-0.23%
DHC Stock Price & Performance
Recommendation
-
Div Yield
-
P/E (Last 12 Month)
29.09
Upside
-
Target Price (Mean)
-
Open
43.20 SAR
Previous Close
43.00 SAR
Turnover
3.67M SAR
EPS
1.485 SAR
Volume
85,384
Transactions
327
Market Cap
3.06B SAR
IPO Date
16-Dec-2012
Analyst Estimates
| EPS | Revenue | |
|---|---|---|
| Mean Estimate |  | |
| Smart Estimate | | |
| Predicted Surprise | | |
| Mean Chg % | | |
Starmine Models
StarMine provides a suite of proprietary alpha-generating analytics and models spanning sectors, regions, and markets.
| Bullish | |
|---|---|
| Value Momentum | |
| Intrinsic Valuation | |
| Relative Valuation | |
| Credit Risk - Smart Ratios | |
| Credit Risk- Text Mining | |
| Bearish | |
|---|---|
| Price Momentum | |
About Dallah Healthcare Company
Business Summary
Ownership and operation of general hospitals. Through its main subsidiaries, manufacture and distribution of branded drugs; offers maintenance services to hospitals and medical centers.
Country of Incorporation
Ownership Type
Established In
1994
Primary Sector
Number of Employees
3000
Stock Listing
| ID | Stock Type | Currency | Exchange | Symbol |
|---|---|---|---|---|
| 4004.SSE | Ordinary | SAR | Saudi SE | 4004 |
Contact details
Primary address
Al Nakheel TowerKing Fahad Road 1157
2nd Floor
Al Nakheel Area
87833
Saudi Arabia
Riyadh
11652
CONTACT
- Tel: +966 11-299-5555
- Tel: +966 11-225-5065
- Fax: +966 11-470-2748
- Fax: +966 11-225-0602
- Fax: +966 11-455-0803
- Email: www.dallahhealth.com
Region
RiyadhOwnership
Ownership
| Investor | Holding | No. of Shares | Last Update |
|---|---|---|---|
| | | |
| | | |
Holding Concentrations
| Investor | Holding | No. of Shares | Last Update |
|---|---|---|---|
| | | |
| | | |
Financials
Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing
Executives
Dr Ahmad Bin Saleh Babaeer
Chief Executive Officer and Managing Director
Mr Khalid Mohammed Ali Al Saudi
Chief Financial Officer
Dr Adnan Sulaiman Al Abdul Karim
Executive Vice President, Operations
Board Members
Mr Tariq Othman Abdullah Al Qusabi
Chairman
Mr Mohieddine Saleh Kamel
Director
Dr Abdulrahman Abdulaziz Al-Swailim
Director
Company information provided by © 2019 Thomson Reuters
Thomson Reuters research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).
Morning Briefing
Thursday Outlook: Investors on edge as tariffs, UK election, ECB loom
Oil prices edge higher as OPEC revises forecast; Aramco flotation propels Saudi bourse into global top ten
Read MoreStock Market Data
Powered By Knowledge Direct